Search clinical trials for: healthy subjects

Total 40063 results

Calico Life Sciences LLC
AbbVie

Active, not recruiting

A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects

Healthy

United States
Shandong Suncadia Medicine Co., Ltd.

Completed

Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects

Obstructive Hypertrophic Cardiomyopathy

China
Hospices Civils de Lyon

Completed

Tolerance of an Immersive Virtual Reality Task Evaluating the Spatial Memory of Elderly Subjects (REVIAGE)

Healthy Participants

France
Principia Biopharma, a Sanofi Company

Completed

Pharmacokinetics (PK) of Rilzabrutinib (PRN1008) in Healthy Japanese and Caucasian Subjects

Healthy Volunteers

United States
Genmab
AbbVie

Active, not recruiting

Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With R/R B-NHL (EPCORE™ NHL-3)

Follicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma

Japan
National Institute of Allergy and Infectious Diseases...

Completed

Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects

Rabies | Rabies Immunisation

United States
AJNA Australia Pty Ltd

Active, not recruiting

A SAD, MAD and Food Effect Study to Evaluate the Safety, Tolerability, PK, and PD of AJA001 in Healthy Subjects

Healthy Volunteers

Australia
Zhejiang Echon Biopharm Limited

Active, not recruiting

Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects

Healthy

China
Zhejiang Echon Biopharm Limited

Active, not recruiting

Safety and Efficacy Study of GB001 Recombinant Peptide Spray in Subjects With Mild Recurrent Aphthous Ulcers

Healthy

China
Instituto de Investigación Biomédica de Salamanca
Instituto de Salud Carlos III

Completed

Effectiveness of the Use of a Mobile Tool in Improving Lifestyles

Healthy Subjects Without Cardiovascular Disease

Spain
University of California, Davis
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Suspended

Single-tracer Multiparametric PET Imaging

Cardiovascular Disease | Healthy Subjects

United States
Alebund Pharmaceuticals

Completed

A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in Healthy Chinese Participants

Healthy Subjects

China
Alebund Pty Ltd

Completed

A Safety, Tolerability, and Pharmacokinetics Study of AP303 in Healthy Subjects

Healthy Subjects

Australia
Applied Therapeutics, Inc.

Completed

Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia

Classic Galactosemia

United States
Cutia Therapeutics（Wuxi）Co.,Ltd

Completed

A Phase 1 Clinical Study of CU-20401 in Chinese Healthy Population

Healthy Subjects

China
Alvotech Swiss AG

Completed

AVT03 With Xgeva in Healthy Male Subjects

This is a Phase I Study Conducted in Healthy Volunteers

United Kingdom, South Africa, Poland
Alvotech Swiss AG

Completed

AVT03 With Prolia in Healthy Male Subjects

Healthy Male Subjects

South Africa, Australia, New Zealand
Sinovac Biotech Co., Ltd

Completed

A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Seasonal Influenza

China
National Institute of Mental Health (NIMH)

Completed

Studies of Frontal Lobe Brain Functioning in Schizophrenia

Schizophrenia | Parkinson Disease | Healthy Subjects

United States
AstraZeneca

Active, not recruiting

A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects

Non-alcoholic Steatohepatitis (NASH)

United States
AstraZeneca

Active, not recruiting

Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia

Untreated Chronic Lymphocytic Leukemia

Thailand, Vietnam, Philippines, China, Taiwan
Momenta Pharmaceuticals, Inc.

Terminated

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

Immune Thrombocytopenic Purpura (ITP)

United States, Poland, Hungary, Netherlands, Italy, Spain, Belgium
Novartis Vaccines

Completed

Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects

Influenza

Finland, United States, Poland
Scilex Pharmaceuticals, Inc.

Completed

Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects

Healthy
Cidara Therapeutics Inc.

Completed

A Single Ascending Dose Study of CD101 IV in Healthy Subjects

Healthy

United States
Ology Bioservices
United States Department of Defense

Active, not recruiting

Single or Repeat Dose of G03-52-01 in Adult Subjects

Healthy | Botulinum Toxin

United States
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Terminated

A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects

Healthy Subject

China
University of Alabama at Birmingham
National Eye Institute (NEI)

Completed

Dyslipidemia and Diabetic Retinopathy (D&D)

Diabetic Retinopathy | Dyslipidemia

United States
OrsoBio, Inc

Completed

A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants

Healthy Subjects

New Zealand
Alnylam Pharmaceuticals

Terminated

A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis | NASH

United States, Bulgaria, United Kingdom, Belgium, Turkey
Basilea Pharmaceutica

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects

Fungal Infection

Netherlands
Akeso

Completed

A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Subjects

Healthy Male Subjects

China
Alzheon Inc.
National Institute on Aging (NIA)

Active, not recruiting

An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects (APOLLOE4)

Early Alzheimer's Disease

United States, Spain, Canada, Netherlands, Czechia, United Kingdom, France, Germany, Iceland
Amgen

Completed

Single Ascending Dose Study of AMG 570 in Healthy Subjects

Systemic Lupus Erythematosus

United States
Centre Hospitalier Universitaire de Nīmes

Completed

Peripheral Immunological Effects of High-dose Vitamin D Treatment in Healthy Subjects (VDSS)

Vitamin d Deficiency

France
Zhejiang Echon Biopharm Limited

Active, not recruiting

Safety,Tolerability,and Pharmacokinetics Profiles of GB001 Recombinant Peptide Spray in Healthy Subjects

Healthy

China
Alebund Pty Ltd

Completed

A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers

Healthy Subjects

Australia
CSL Behring

Completed

Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome (AEGIS-II)

Acute Coronary Syndrome

United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czechia, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Latvi... and more
Prof. Dominique de Quervain, MD

Completed

Influence of Luteolin for Two Weeks on Memory in Healthy Subjects (LuMus2-2023)

Memory

Switzerland
University of Saskatchewan

Completed

Walking Aid Assessment, Arm Strength and Force Under the Foot in Normal Subjects

Adolescent | Healthy | Gait | Aged | Young Adult | Middle Age | Physical Examination

Canada
Gødstrup Hospital

Completed

Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity in Healthy Subjects (KETO)

Ketosis | Ketonemia

Denmark
Madrigal Pharmaceuticals, Inc.

Enrolling by invitation

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function

Renal Impairment

United States
Athos Therapeutics Inc
Syneos Health; Athos Therapeutics Australia Pty Ltd

Completed

Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects

Autoimmune Diseases | Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Australia
Ono Pharmaceutical Co. Ltd

Completed

Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and PK of ONO-2910 in Japanese and Caucasian Subjects

Healthy Volunteers

Japan
Ono Pharmaceutical Co. Ltd

Completed

Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male Subjects

Healthy Volunteers

Japan
University of California, San Francisco

Enrolling by invitation

Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research (BHR)

Healthy | Neurodegenerative Disease

United States
Shanghai Yao Yuan Biotechnology Ltd. (also known...

Active, not recruiting

Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects

Healthy | Safety and Tolerability

United States
Asceneuron S.A.

Completed

Positron Emission Tomography Study in Healthy Subjects to Determine the Relationship Between Plasma Concentration and Brain Target Occupancy of ASN51

Alzheimer Disease

United Kingdom
SFJ Pharmaceuticals, Inc.

Completed

Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects

Healthy

United States
Universidad de Murcia

Completed

Evaluation of the Beneficial Health Effects of an Additive-free Meat Product in Healthy Subjects (HIPOCARNE)

Inflammation | Oxidative Stress | Food Toxicity

Spain

Search clinical trials for: healthy subjects

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations